Patents by Inventor Jorg Schaffner

Jorg Schaffner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210070822
    Abstract: The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.
    Type: Application
    Filed: October 21, 2020
    Publication date: March 11, 2021
    Inventors: Arndt Dietrich, Bernhard Janowski, Jörg Schäffner, Ulrich Blaschke
  • Patent number: 10844103
    Abstract: The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: November 24, 2020
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Arndt Dietrich, Bernhard Janowski, Jörg Schäffner, Ulrich Kurt Blaschke
  • Publication number: 20180094036
    Abstract: The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.
    Type: Application
    Filed: October 10, 2017
    Publication date: April 5, 2018
    Applicant: Sandoz AG
    Inventors: Arndt Dietrich, Bernhard Janowski, Jörg Schäffner, Ulrich Kurt Blaschke
  • Patent number: 9815879
    Abstract: The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: November 14, 2017
    Assignee: Sandoz AG
    Inventors: Arndt Dietrich, Bernhard Janowski, Jörg Schäffner, Ulrich Kurt Blaschke
  • Patent number: 8510875
    Abstract: An indicator that the cartridge is draining slowly is placed on top of the cartridge. When slow draining causes urine to pool on top of the cartridge, liquid enters a float housing, causing an indicator to change color. The indicator is visible through a lens in a diverter. The indicator may be a disk that undergoes a chemical reaction to change color or a float that flips over to reveal a side having a different color. When the cartridge is operating properly, the float displays a first color. Flipping of the float reveals a second color to the observer. A color change indicates, such as by signaling, that the cartridge needs to be replaced.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: August 20, 2013
    Inventors: Thomas Helbig, Michael L. Higgins, Erik Brown, Martin Oberlack, Jorg Schaffner, Martin Bremerich, Joerg-Michael Fitzke
  • Publication number: 20080260684
    Abstract: The present invention relates to a method for obtaining recombinant granulocyte-colony stimulating factor (G-CSF), comprising at least one cation exchange chromatography and at least one hydrophobic interaction chromatography, wherein said two chromatographic steps are immediately consecutive in optional order. In particular, the present invention relates to a method for purifying G-CSF from a mixture of G-CSF and other proteins, comprising two cation exchange chromatography steps which are conducted before and after a hydrophobic interaction chromatography, respectively.
    Type: Application
    Filed: July 14, 2006
    Publication date: October 23, 2008
    Applicant: BIOCEUTICALS ARZNEIMITTEL AG
    Inventors: Arndt Dietrich, Bernhard Janowski, Jorg Schaffner, Ulrich Kurt Blaschke
  • Publication number: 20070209979
    Abstract: An indicator that the cartridge is draining slowly is placed on top of the cartridge. When slow draining causes urine to pool on top of the cartridge, liquid enters a float housing, causing an indicator to change color. The indicator is visible through a lens in a diverter. The indicator may be a disk that undergoes a chemical reaction to change color or a float that flips over to reveal a side having a different color. When the cartridge is operating properly, the float displays a first color. Flipping of the float reveals a second color to the observer. A color change indicates that the cartridge needs to be replaced.
    Type: Application
    Filed: December 4, 2006
    Publication date: September 13, 2007
    Inventors: Thomas Helbig, Michael Higgins, Erik Brown, Martin Oberlack, Jorg Schaffner, Martin Bremerich, Joerg-Michael Fitzke